4//SEC Filing
THERASENSE INC 4
Accession 0001267399-04-000030
CIK 0001073695operating
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 2:36 PM ET
Size
5.9 KB
Accession
0001267399-04-000030
Insider Transaction Report
Form 4
THERASENSE INCTHER
LORD JONATHAN T MD
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2004-04-05$17.95/sh−30,000$538,500→ 0 totalExercise: $9.05From: 1988-08-08Exp: 2013-05-09→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This option vests over a three year period and was cancelled pursuant to the merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
Documents
Issuer
THERASENSE INC
CIK 0001073695
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001073695
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 2:36 PM ET
- Size
- 5.9 KB